Drugs

What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?
Robert L Avery

British Journal of Ophthalmology Jun 2014, 98 (Suppl 1) i7-i10; DOI: 10.1136/bjophthalmol-2013-303844
Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
Ivan Goldberg, Rafael Gil Pina, Aitor Lanzagorta-Aresti, Rhett M Schiffman, Charlie Liu, Marina Bejanian

British Journal of Ophthalmology Jul 2014, 98 (7) 926-931; DOI: 10.1136/bjophthalmol-2013-304064
Treatment of orbital vascular malformations with intralesional injection of pingyangmycin
Han Yue, Jiang Qian, Victor M Elner, Jie Guo, Yi-Fei Yuan, Rui Zhang, Qin Ge

British Journal of Ophthalmology Jun 2013, 97 (6) 739-745; DOI: 10.1136/bjophthalmol-2012-302900
Vernal keratoconjunctivitis: an update
Stefan De Smedt, Gerhild Wildner, Philippe Kestelyn

British Journal of Ophthalmology Jan 2013, 97 (1) 9-14; DOI: 10.1136/bjophthalmol-2011-301376

Main menu